{"nct_id":"NCT05384119","title":"Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer","status":"TERMINATED","status_verified_date":"2025-02","start_date":"2023-01-09","start_date_type":"ACTUAL","primary_completion_date":"2024-04-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TVRD"]}